M
GLUE//CIK 0001826457
Monte Rosa Therapeutics, Inc.
Market Data
$14.39−$8.39 (−36.83%)
GLUE · Last trade
Prev Close
$22.78
Range (29d)
$13.77 – $22.68
Recent Filings
- SCHEDULE 13G/A16.4 KBMonte Rosa Therapeutics, Inc.Aug 14, 4:23 PM ET·0000919574-26-005533
- SCHEDULE 13G15.1 KBMonte Rosa Therapeutics, Inc.Aug 14, 4:10 PM ET·0000902664-26-003506
- 10-Q10.8 MBMonte Rosa Therapeutics, Inc.Aug 6, 7:09 AM ET·0001193125-26-336711
- 8-K499.8 KBMonte Rosa Therapeutics, Inc.Aug 6, 7:04 AM ET·0001193125-26-336681
- 8-K188.3 KBMonte Rosa Therapeutics, Inc.Jun 11, 4:01 PM ET·0001193125-26-267465
- 10-Q9.2 MBMonte Rosa Therapeutics, Inc.May 7, 7:30 AM ET·0001193125-26-210358
- 8-K453.2 KBMonte Rosa Therapeutics, Inc.May 7, 7:05 AM ET·0001193125-26-210298
- 10-K35.8 MBMonte Rosa Therapeutics, Inc.Mar 17, 7:14 AM ET·0001193125-26-109360
- 8-K516.5 KBMonte Rosa Therapeutics, Inc.Mar 17, 7:04 AM ET·0001193125-26-109353
- 8-K168.1 KBMonte Rosa Therapeutics, Inc.Feb 10, 4:01 PM ET·0001193125-26-044616
Insiders
10- BASKETT FOREST10% Owner
- Behbahani AliDirector
- Blackwell KimberlyDirector
- Bolzon Bradley J PhDDirector, 10% Owner
- Bowen MatthewPrincipal Accounting Officer
- Castle John C.Chief Data Scientist
- Champoux JenniferChief Operating Officer
- Chang Carmen10% Owner
- Chen Bihua10% Owner
- Cormorant Asset Management, LPFormer 10% Owner
Tickers
Addresses
business
321 HARRISON AVENUE SUITE 900
BOSTON, MA, 02118
mailing
321 HARRISON AVENUE SUITE 900
BOSTON, MA, 02118
Former Names
- Monte Rosa Therapeutics, Inc.2026-08-14